Affiliation:
1. Medical School, The University of Western Australia, Perth, Western Australia
Abstract
Background: Tapentadol is a novel atypical opioid. Anecdotal evidence suggests that tapentadol has a lower toxicity than conventional opioids. Objectives: To evaluate all single-drug mortality due to tapentadol and assess serious adverse events caused by tapentadol. Methods: The Preferred Reporting Items for Systematic review and Meta-Analysis Protocols (PRISMA-P) reporting guidelines, an evidence-based minimum set of items for reporting in systematic reviews, were followed in this systematic review. Results: 24 peer-reviewed papers were identified. They indicate that tapentadol toxicity can cause mortality and serious adverse effects. Conclusion(s): At least four confirmed fatalities, and serious adverse effects have been documented for individuals abusing or using tapentadol as prescribed. Serious adverse effects of tapentadol use may include respiratory depression, confusion, coma, hallucination/delusion, seizures, tachycardia, hypertension, agitation, tremor, miosis, hypotension, dyspnea, electrolyte abnormality, atrial fibrillation or severe upper abdominal pain. Tapentadol is unlikely to cause serotonin syndrome. The toxicity of tapentadol is significantly less than pure mu opioids, such as oxycodone.
Reference57 articles.
1. Department of Health. Tapentadol, tablet, 50mg, 100mg, 150mg, 200mg and 250mg (as hydrochloride) (sustained release), Palexia SR®– November 2013. The Pharmaceutical Benefits Scheme 2017 (23 August 2013). www.pbs.gov.au/info/industry/listing/elements/pbac-meetings/psd/2013-11/tapentadol.
2. US FDA Drug Approval Package Tapentadol Hydrochloride Tablets. Application No.: 022304, Approval Date: 12/24/2008. www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022304s000_TOC.cfm.
3. Emc. Palexia SR prolonged release tablets (2018). www.medicines.org.uk/emc/product/5158/smpc.
4. Tapentadol: mit zwei Mechanismen in einem Molekül wirksam gegen nozizeptive und neuropathische Schmerzen
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献